prikaz prve stranice dokumenta Miller Fisher syndrome following Pfizer COVID-19 vaccine
  Preuzmi
PDF 426.66 KB
Znanstveni rad - Prikaz slučaja
Miller Fisher syndrome following Pfizer COVID-19 vaccine
Neurological Sciences, 43 (2022), 3; 1495-1497. https://doi.org/10.1007/s10072-021-05776-0
Abičić, Ana; Adamec, Ivan; Habek, Mario

Povezani objekti
COVID-19 | Virtualna zbirka

Institucijski repozitorij: Dr Med - digitalni repozitorij Medicinskog fakulteta Sveučilišta u Zagrebu

Citirajte ovaj rad

Abičić, A., Adamec, I. i Habek, M. (2022). Miller Fisher syndrome following Pfizer COVID-19 vaccine. Neurological Sciences, 43. (3), 1495-1497. doi: 10.1007/s10072-021-05776-0

Abičić, Ana, et al. "Miller Fisher syndrome following Pfizer COVID-19 vaccine." Neurological Sciences, vol. 43, br. 3, 2022, str. 1495-1497. https://doi.org/10.1007/s10072-021-05776-0

Abičić, Ana, Ivan Adamec i Mario Habek. "Miller Fisher syndrome following Pfizer COVID-19 vaccine." Neurological Sciences 43, br. 3 (2022): 1495-1497. https://doi.org/10.1007/s10072-021-05776-0

Abičić, A., Adamec, I. i Habek, M. (2022) 'Miller Fisher syndrome following Pfizer COVID-19 vaccine', Neurological Sciences, 43(3), str. 1495-1497. doi: 10.1007/s10072-021-05776-0

Abičić A, Adamec I, Habek M. Miller Fisher syndrome following Pfizer COVID-19 vaccine. Neurological Sciences [Internet]. 03.2022. [pristupljeno 29.12.2024.];43(3):1495-1497. doi: 10.1007/s10072-021-05776-0

A. Abičić, I. Adamec i M. Habek, "Miller Fisher syndrome following Pfizer COVID-19 vaccine", Neurological Sciences, vol. 43, br. 3, str. 1495-1497, Ožujak 2022. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:851869. [Citirano: 29.12.2024.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:105:851869
Podaci o radu
Naslov (engleski)Miller Fisher syndrome following Pfizer COVID-19 vaccine
AutorAna Abičić
AutorIvan Adamec
AutorMario Habek
Autorova ustanovaSveučilište u Zagrebu
Medicinski fakultet
(HRVATSKI INSTITUT ZA ISTRAŽIVANJE MOZGA)
Autorova ustanovaSveučilište u Zagrebu
Medicinski fakultet
(KATEDRA ZA NEUROLOGIJU)
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Neurologija
Sažetak (engleski)
Introduction: Miller Fisher syndrome (MFS) is a rare variant of Guillain-Barre syndrome characterized by ataxia, areflexia, and ophthalmoplegia. We present a case of MFS following Pfizer COVID-19 vaccine. ----- Case presentation: A previously healthy 24-year-old female presented with binocular horizontal diplopia 18 days after receiving the first dose of Pfizer COVID-19 vaccine (Comirnaty®). Anti-ganglioside testing revealed positive anti-GQ1b antibodies. Intravenous immunoglobulins were administered, in a dose of 2 g per kg of body weight over 5 days. On a follow-up exam 3 weeks after the treatment, clinical improvement was noted with normal bulbomotor examination. ----- Conclusion: Patients with acute ophthalmoplegia occurring after COVID-19 vaccination should be screened for the presence of anti-GQ1b antibody. If the antibody is present, intravenous immunoglobulin should be administered as it may hasten clinical improvement.
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeZnanstveni rad - Prikaz slučaja
Status objaveObjavljen
Vrsta recenzijeRecenziran
Verzija publikacijeObjavljena verzija rada (izdavačev PDF)
Naslov časopisaNeurological Sciences
Brojčani podacivol. 43, br. 3, str. 1495-1497
p-ISSN1590-1874
e-ISSN1590-3478
DOIhttps://doi.org/10.1007/s10072-021-05776-0
URN:NBNurn:nbn:hr:105:851869
Datum objave publikacije2022-03
URL dokumentahttps://link.springer.com/10.1007/s10072-021-05776-0
Vrsta resursaTekst
Prava pristupaOtvoreni pristup
Uvjeti korištenjaIkona licence Zaštićeno autorskim pravom.
Datum i vrijeme pohrane2022-03-09 09:00:32